K. . Khan, “Efficacy and safety of sitagliptin, metformin and pioglitazone fixed-dose combination therapy (100 mg/1000mg and 15 mg respectively) as a first-line treatment in obese type 2 diabetes with high insulin resistance”, IJMBS, vol. 9, no. 1, pp. 247–251, Feb. 2025.